More than 300 patients, caregivers, health care professionals, researchers, donors, and supporters gathered to celebrate “Trailblazing a Decade of CAR T-Cell Therapy: 10 Years of Innovation at Nebraska Medicine and UNMC.”
Question: I heard that oral sex could cause throat cancer. Is that actually true? Answered by Elizabeth Bradford Bell, MD, otolaryngologist and head and neck surgeon.
Previous attempts to treat Christine’s Chronic Lymphocytic Leukemia (CLL) had failed. She participated in a clinical trial and subsequently went through a CAR T-cell transplant at the NCI-designated Fred & Pamela Buffett Cancer Center.
The Fred & Pamela Buffett Cancer Center – Nebraska Medical Center is one of only 73 cancer centers in the U.S. with the special National Cancer Institute (NCI) designation.
Every cancer treatment available today started as a clinical trial. For patients facing cancer, choosing a center deeply involved in research can mean access to tomorrow’s treatments today.
Jan Janisch-Hanzlik had been having strange symptoms for several years, was diagnosed with MS, and referred to Rana Zabad, MD. Dr. Zabad offered her a new option: enrollment in a first-of-its-kind clinical trial using allogeneic CAR T-cell therapy.
ALS (amyotrophic lateral sclerosis) is a deadly disease that slowly takes away a person’s ability to move, speak, eat and breathe. While treatments can help with symptoms, there is no cure, making research crucial.
Researchers are investigating whether metformin, a common diabetes medication, could help reduce the risk of developing this painful joint condition after ACL reconstruction surgery.
Researchers are investigating a novel combination therapy that could offer hope for patients with recurrent high-grade glioma, a challenging form of brain cancer.
You’re about to leave the Nebraska Medicine website. The other site may collect information about your visit, including your IP address. Do you want to continue?